Roles of long non‑coding RNAs in the hallmarks of glioma (Review)
- Authors:
- Bing-Zhou Xue
- Wei Xiang
- Qing Zhang
- Yi-Hao Wang
- Hao-Fei Wang
- Dong-Ye Yi
- Nan-Xiang Xiong
- Xiao-Bing Jiang
- Hong-Yang Zhao
- Peng Fu
-
Affiliations: Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China - Published online on: August 4, 2020 https://doi.org/10.3892/ol.2020.11944
- Article Number: 83
-
Copyright: © Xue et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
|
Hanahan D and Weinberg RA: Hallmarks of cancer: The Next Generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Fouad YA and Aanei C: Revisiting the hallmarks of cancer. Am J Cancer Res. 7:1016–1036. 2017.PubMed/NCBI | |
|
Quail DF and Joyce JA: The Microenvironmental landscape of brain tumors. Cancer Cell. 31:326–341. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Weiss N, Miller F, Cazaubon S and Couraud P: The blood-brain barrier in brain homeostasis and neurological diseases. Biochim Biophys. 1788:842–857. 2009. View Article : Google Scholar | |
|
Wolburg H, Wolburg-Buchholz K, Kraus J, Rascher-Eggstein G, Liebner S, Hamm S, Duffner F, Grote E, Risau W and Engelhardt B: Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme. Acta Neuropathol. 105:586–592. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Jain RK, di Tomaso E, Duda DG, Loeffler JS, Sorensen AG and Batchelor TT: Angiogenesis in brain tumours. Nat Rev Neurosci. 8:610–622. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Plate KH, Breier G, Weich HA and Risau W: Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature. 359:845–848. 1992. View Article : Google Scholar : PubMed/NCBI | |
|
Gavard J and Gutkind JS: VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol. 8:1223–1234. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
ENCODE Project Consortium, . Birney E, Stamatoyannopoulos JA, Dutta A, Guigo R, Gingeras TR, Margulies EH, Weng Z, Snyder M, Dermitzakis ET, et al: Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature. 447:799–816. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F, et al: Landscape of transcription in human cells. Nature. 489:101–108. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Wang DQ, Fu P, Yao C, Zhu LS, Hou TY, Chen JG, Lu Y, Liu D and Zhu LQ: Long Non-coding RNAs, Novel culprits, or bodyguards in neurodegenerative diseases. Mol Ther Nucleic Acids. 10:269–276. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Rynkeviciene R, Simiene J, Strainiene E, Stankevicius V, Usinskiene J, Miseikyte Kaubriene E, Meskinyte I, Cicenas J and Suziedelis K: Non-coding RNAs in Glioma. Cancers (Basel). 11:172018. View Article : Google Scholar | |
|
Kornienko AE, Guenzl PM, Barlow DP and Pauler FM: Gene regulation by the act of long non-coding RNA transcription. BMC Biol. 11:592013. View Article : Google Scholar : PubMed/NCBI | |
|
Ulitsky I and Bartel DP: lincRNAs: Genomics, evolution, and mechanisms. Cell. 154:26–46. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Tragante V, Moore JH and Asselbergs FW: The ENCODE project and perspectives on pathways. Genet Epidemiol. 38:275–280. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Bhan A and Mandal SS: Long noncoding RNAs: Emerging stars in gene regulation, epigenetics and human disease. ChemMedChem. 9:1932–1956. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Yuan J, Yue H, Zhang M, Luo J, Liu L, Wu W, Xiao T, Chen X, Chen X, Zhang D, et al: Transcriptional profiling analysis and functional prediction of long noncoding RNAs in cancer. Oncotarget. 16:72016. | |
|
Tsai M, Spitale RC and Chang HY: Long intergenic noncoding RNAs: New links in cancer progression. Cancer Res. 71:3–7. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Xie H, Ma H and Zhou D: Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma. Biomed Res Int. 2013:1361062013. View Article : Google Scholar : PubMed/NCBI | |
|
Parasramka MA, Maji S, Matsuda A, Yan IK and Patel T: Long non-coding RNAs as novel targets for therapy in hepatocellular carcinoma. Pharmacol Ther. 161:67–78. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang L, Yang F, Yuan J, Yuan S, Zhou W, Huo X, Xu D, Bi H, Wang F and Sun S: Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma. Carcinogenesis. 34:577–586. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Dai M, Li S and Qin X: Colorectal neoplasia differentially expressed: A long noncoding RNA with an imperative role in cancer. Onco Targets Ther. 11:3755–3763. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Du P, Zhao H, Peng R, Liu Q, Yuan J, Peng G and Liao Y: LncRNA-XIST interacts with miR-29c to modulate the chemoresistance of glioma cell to TMZ through DNA mismatch repair (MMR) pathway. Biosci Rep. 37:BSR201706962017. View Article : Google Scholar : PubMed/NCBI | |
|
Yu H, Xue Y, Wang P, Liu X, Ma J, Zheng J, Li Z, Li Z, Cai H and Liu Y: Knockdown of long non-coding RNA XIST increases blood-tumor barrier permeability and inhibits glioma angiogenesis by targeting miR-137. Oncogenesis. 6:e3032017. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou H, Ma Y, Zhong D and Yang L: Knockdown of lncRNA HOXD-AS1 suppresses proliferation, migration and invasion and enhances cisplatin sensitivity of glioma cells by sponging miR-204. Biomed Pharmacother. 112:1086332019. View Article : Google Scholar : PubMed/NCBI | |
|
Cui B, Li B, Liu Q and Cui Y: lncRNA CCAT1 promotes glioma tumorigenesis by sponging miR-181b. J Cell Biochem. 118:4548–4557. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Wang O, Huang Y, Wu H, Zheng B, Lin J and Jin P: LncRNA LOC728196/miR-513c axis facilitates glioma carcinogenesis by targeting TCF7. Gene. 679:119–125. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Wallmen B, Schrempp M and Hecht A: Intrinsic properties of Tcf1 and Tcf4 splice variants determine cell-type-specific Wnt/β-catenin target gene expression. Nucleic Acids Res. 40:9455–9469. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Li X, Xue L and Peng Q: Tunicamycin inhibits progression of glioma cells through downregulation of the MEG-3-regulated wnt/β-catenin signaling pathway. Oncol Lett. 15:8470–8476. 2018.PubMed/NCBI | |
|
Li X, Shen F, Huang L, Hui L, Liu R, Ma Y and Jin B: lncRNA small nucleolar RNA host gene 20 predicts poor prognosis in glioma and promotes cell proliferation by silencing P21. Oncotargets Ther. 12:805–814. 2019. View Article : Google Scholar | |
|
Hu Y, Kang C, Zhao J, Nie Y, Zheng L, Li H, Li X, Wang Q and Qiu Y: LncRNA PLAC2 down-regulates RPL36 expression and blocks cell cycle progression in glioma through a mechanism involving STAT1. J Cell Mol Med. 22:497–510. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Hu S, Xu L, Li L, Luo D, Zhao H, Li D and Peng B: Overexpression of lncRNA PTENP1 suppresses glioma cell proliferation and metastasis in vitro. Onco Targets Ther. 12:147–156. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Q, Zhang J, Liu Y, Zhang W, Zhou J, Duan R, Pu P, Kang C and Han L: A novel cell cycle-associated lncRNA, HOXA11-AS, is transcribed from the 5-prime end of the HOXA transcript and is a biomarker of progression in glioma. Cancer Lett. 373:251–259. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Cui Z, Ren S, Lu J, Wang F, Xu W, Sun Y, Wei M, Chen J, Gao X, Xu C, et al: The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor. Urol Oncol. 31:1117–1123. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Fang Z, Xu C, Li Y, Cai X, Ren S, Liu H, Wang Y, Wang F, Chen R, Qu M, et al: A feed-forward regulatory loop between androgen receptor and PlncRNA-1 promotes prostate cancer progression. Cancer Lett. 374:62–74. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Jin Y, Cui Z, Li X, Jin X and Peng J: Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer. Oncotarget. 8:26090–26099. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Wang X, Yan Y, Zhang C, Wei W, Ai X, Pang Y and Bian Y: Upregulation of lncRNA PlncRNA-1 indicates the poor prognosis and promotes glioma progression by activation of Notch signal pathway. Biomed Pharmacother. 103:216–221. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Yao J, Zhou B, Zhang J, Geng P, Liu K, Zhu Y and Zhu W: A new tumor suppressor LncRNA ADAMTS9-AS2 is regulated by DNMT1 and inhibits migration of glioma cells. Tumour Biol. 35:7935–7944. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Liao Y, Shen L, Zhao H, Liu Q, Fu J, Guo Y, Peng R and Cheng L: LncRNA CASC2 Interacts With miR-181a to modulate glioma growth and resistance to TMZ Through PTEN pathway. J Cell Biochem. 118:1889–1899. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Dorasamy MS, Choudhary B, Nellore K, Subramanya H and Wong P: Dihydroorotate dehydrogenase Inhibitors Target c-Myc and arrest melanoma, myeloma and lymphoma cells at S-phase. J Cancer. 8:3086–3098. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Kang M, Xia P, Hou T, Qi Z, Liao S and Yang X: MicroRNA-190b inhibits tumor cell proliferation and induces apoptosis by regulating Bcl-2 in U2OS osteosarcoma cells. Pharmazie. 72:279–282. 2017.PubMed/NCBI | |
|
Liu Z, Liu H, Yuan X, Wang Y, Li L, Wang G, Song J, Shao Z and Fu R: Downregulation of Pim-2 induces cell cycle arrest in the G0/G1 phase via the p53-non-dependent p21 signaling pathway. Oncol Lett. 15:4079–4086. 2018.PubMed/NCBI | |
|
Ju X, Yu H, Liang D, Jiang T, Liu Y, Chen L, Dong Q and Liu X: LDR reverses DDP resistance in ovarian cancer cells by affecting ERCC-1, Bcl-2, Survivin and Caspase-3 expressions. Biomed Pharmacother. 102:549–554. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Dai W, Tian C and Jin S: Effect of lncRNA ANRIL silencing on anoikis and cell cycle in human glioma via microRNA-203a. Onco Targets Ther. 11:5103–5109. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Seward S, Semaan A, Qazi AM, Gruzdyn OV, Chamala S, Bryant CC, Kumar S, Cameron D, Sethi S, Ali-Fehmi R, et al: EZH2 blockade by RNA interference inhibits growth of ovarian cancer by facilitating re-expression of p21(waf1/cip1) and by inhibiting mutant p53. Cancer Lett. 336:53–60. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Taniguchi H, Jacinto FV, Villanueva A, Fernandez AF, Yamamoto H, Carmona FJ, Puertas S, Marquez VE, Shinomura Y, Imai K and Esteller M: Silencing of Kruppel-like factor 2 by the histone methyltransferase EZH2 in human cancer. Oncogene. 31:1988–1994. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Fei F, He Y, He S, He Z, Wang Y, Wu G and Li M: LncRNA SNHG3 enhances the malignant progress of glioma through silencing KLF2 and p21. Biosci Rep. 38:BSR201804202018. View Article : Google Scholar : PubMed/NCBI | |
|
Cai G, Zhu Q, Yuan L and Lan Q: LncRNA SNHG6 acts as a prognostic factor to regulate cell proliferation in glioma through targeting p21. Biomed Pharmacother. 102:452–457. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Lu YF, Cai XL, Li ZZ, Lv J, Xiang YA, Chen JJ, Chen WJ, Sun WY, Liu XM and Chen JB: LncRNA SNHG16 Functions as an oncogene by sponging MiR-4518 and Up-regulating PRMT5 expression in glioma. Cell Physiol Biochem. 45:1975–1985. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Guo LP, Zhang ZJ, Li RT, Li HY and Cui YQ: Influences of LncRNA SNHG20 on proliferation and apoptosis of glioma cells through regulating the PTEN/PI3K/AKT signaling pathway. Eur Rev Med Pharmacol Sci. 23:253–261. 2019.PubMed/NCBI | |
|
Li J, Zhang M, An G and Ma Q: LncRNA TUG1 acts as a tumor suppressor in human glioma by promoting cell apoptosis. Exp Biol Med (Maywood). 241:644–649. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Cai H, Liu X, Zheng J, Xue Y, Ma J, Li Z, Xi Z, Li Z, Bao M and Liu Y: Long non-coding RNA taurine upregulated 1 enhances tumor-induced angiogenesis through inhibiting microRNA-299 in human glioblastoma. Oncogene. 36:318–331. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Gong X, Liao X and Huang M: LncRNA CASC7 inhibits the progression of glioma via regulating Wnt/β-catenin signaling pathway. Pathol Res Pract. 215:564–570. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Ni W, Luo L, Zuo P, Li R, Xu X, Wen F and Hu D: lncRNA GHET1 down-regulation suppresses the cell activities of glioma. Cancer Biomark. 23:9–22. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
He Z, Wang Y, Huang G, Wang Q, Zhao D and Chen L: The lncRNA UCA1 interacts with miR-182 to modulate glioma proliferation and migration by targeting iASPP. Arch Biochem Biophys 623–624. 1–8. 2017. View Article : Google Scholar | |
|
Horn S, Figl A, Rachakonda PS, Fischer C, Sucker A, Gast A, Kadel S, Moll I, Nagore E, Hemminki K, et al: TERT promoter mutations in familial and sporadic melanoma. Science. 339:959–961. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Tan Y, Tang L, OuYang W, Jiang T, Zhang H and Li S: β-catenin-coordinated lncRNA MALAT1 up-regulation of ZEB-1 could enhance the telomerase activity in HGF-mediated differentiation of bone marrow mesenchymal stem cells into hepatocytes. Pathol Res Pract. 215:546–554. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Fu Z, Luo W, Wang J, Peng T, Sun G, Shi J, Li Z and Zhang B: Malat1 activates autophagy and promotes cell proliferation by sponging miR-101 and upregulating STMN1, RAB5A and ATG4D expression in glioma. Biochem Biophys Res Commun. 492:480–486. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Liu X, Fu Q, Li S, Liang N, Li F, Li C, Sui C, Dionigi G and Sun H: LncRNA FOXD2-AS1 Functions as a Competing Endogenous RNA to Regulate TERT Expression by Sponging miR-7-5p in Thyroid Cancer. Front Endocrinol (Lausanne). 10:2072019. View Article : Google Scholar : PubMed/NCBI | |
|
Dong H, Cao W and Xue J: Long noncoding FOXD2-AS1 is activated by CREB1 and promotes cell proliferation and metastasis in glioma by sponging miR-185 through targeting AKT1. Biochem Biophys Res Commun. 508:1074–1081. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Ni W, Xia Y, Bi Y, Wen F, Hu D and Luo L: FoxD2-AS1 promotes glioma progression by regulating miR-185-5P/HMGA2 axis and PI3K/AKT signaling pathway. Aging (Albany NY). 11:1427–1439. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang X, Yan Y, Hu M, Chen X, Wang Y, Dai Y, Wu D, Wang Y, Zhuang Z and Xia H: Increased level of H19 long noncoding RNA promotes invasion, angiogenesis, and stemness of glioblastoma cells. J Neurosurg. 2016:129–136. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Yan K, Wu Q, Yan DH, Lee CH, Rahim N, Tritschler I, DeVecchio J, Kalady MF, Hjelmeland AB and Rich JN: Glioma cancer stem cells secrete Gremlin1 to promote their maintenance within the tumor hierarchy. Gene Dev. 28:1085–1100. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Fu C, Li D, Zhang X, Liu N, Chi G and Jin X: LncRNA PVT1 Facilitates Tumorigenesis and progression of glioma via regulation of MiR-128-3p/GREM1 Axis and BMP signaling pathway. Neurotherapeutics. 15:1139–1157. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Han Y, Li X, Yan J, Ma C, Zheng X, Zhang J, Zhang D, Meng C, Zhang Z, Ji X, et al: Knockdown of LncRNA PVT1 inhibits glioma progression by regulating miR-424 expression. Oncol Res. 27:681–690. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Zheng J, Hu L, Cheng J, Xu J, Zhong Z, Yang Y and Yuan Z: lncRNA PVT1 promotes the angiogenesis of vascular endothelial cell by targeting miR26b to activate CTGF/ANGPT2. Int J Mol Med. 42:489–496. 2018.PubMed/NCBI | |
|
Hu L, Lv Q, Chen S, Sun B, Qu Q, Cheng L, Guo Y, Zhou H and Fan L: Up-Regulation of long Non-coding RNA AB073614 predicts a poor prognosis in patients with glioma. Int J Environ Res Public Health. 13:4332016. View Article : Google Scholar : PubMed/NCBI | |
|
Li J, Wang Y and Song Y: Knockdown of long noncoding RNA AB073614 inhibits glioma cell proliferation and migration via affecting epithelial-mesenchymal transition. Eur Rev Med Pharmaco. 20:3997–4002. 2016. | |
|
Qin X, Yao J, Geng P, Fu X, Xue J and Zhang Z: LncRNA TSLC1-AS1 is a novel tumor suppressor in glioma. Int J Clin Exp Patho. 7:3065–3072. 2014. | |
|
Jia L, Tian Y, Chen Y and Zhang G: The silencing of LncRNA-H19 decreases chemoresistance of human glioma cells to temozolomide by suppressing epithelial-mesenchymal transition via the Wnt/β-catenin pathway. Onco Targets Ther. 11:313–321. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Li J and Zhou L: Overexpression of lncRNA DANCR positively affects progression of glioma via activating Wnt/β-catenin signaling. Biomed Pharmacother. 102:602–607. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang H, Wei D, Wan L, Yan S and Sun Y: Highly expressed lncRNA CCND2-AS1 promotes glioma cell proliferation through Wnt/β-catenin signaling. Biochem Bioph Res Commun. 482:1219–1225. 2017. View Article : Google Scholar | |
|
Zhang T and Wang Y, Zeng F, Cao H, Zhou H and Wang Y: LncRNA H19 is overexpressed in glioma tissue, is negatively associated with patient survival, and promotes tumor growth through its derivative miR-675. Eur Rev Med Pharmaco. 20:4891–4897. 2016. | |
|
Zhao H, Peng R, Liu Q, Liu D, Du P, Yuan J, Peng G and Liao Y: The lncRNA H19 interacts with miR-140 to modulate glioma growth by targeting iASPP. Arch Biochem Biophys. 610:1–7. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang N, Wang X, Xie X, Liao Y, Liu N, Liu J, Miao N, Shen J and Peng T: lncRNA DANCR promotes tumor progression and cancer stemness features in osteosarcoma by upregulating AXL via miR-33a-5p inhibition. Cancer Lett. 405:46–55. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Yang Y, Hou N, Wang X, Wang L, Chang S, He K, Zhao Z, Zhao X, Song T and Huang C: miR-15b-5p induces endoplasmic reticulum stress and apoptosis in human hepatocellular carcinoma, both in vitro and in vivo, by suppressing Rab1A. Oncotarget. 6:16227–16238. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Xu C, Xiao L, Liu Y, Chen L, Zheng S, Zeng E and Li D: The lncRNA HOXA11-AS promotes glioma cell growth and metastasis by targeting miR-130a-5p/HMGB2. Eur Rev Med Pharmaco. 23:241–252. 2019. | |
|
Liang C, Yang Y, Guan J, Lv T, Qu S, Fu Q and Zhao H: LncRNA UCA1 sponges miR-204-5p to promote migration, invasion and epithelial-mesenchymal transition of glioma cells via upregulation of ZEB1. Pathol Res Pract. 214:1474–1481. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Chen X, Gao Y, Li D, Hao B and Cao Y: LncRNA-TP53TG1 participated in the stress response under glucose deprivation in glioma. J Cell Biochem. 118:4897–4904. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Anastasiou D, Poulogiannis G, Asara JM, Boxer MB, Jiang J, Shen M, Bellinger G, Sasaki AT, Locasale JW, Auld DS, et al: Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science. 334:1278–1283. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao S, Lin Y, Xu W, Jiang W, Zha Z, Wang P, Yu W, Li Z, Gong L, Peng Y, et al: Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science. 324:261–265. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Wang W, Wu F, Zhao Z, Wang K, Huang R, Wang H, Lan Q, Wang J and Zhao J: Long noncoding RNA LINC00152 is a potential prognostic biomarker in patients with high-grade glioma. CNS Neurosci Ther. 24:957–966. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Wang W, Zhao Z, Yang F, Wang H, Wu F, Liang T, Yan X, Li J, Lan Q, Wang J and Zhao J: An immune-related lncRNA signature for patients with anaplastic gliomas. J Neurooncol. 136:263–271. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang EB, Yin DD, Sun M, Kong R, Liu XH, You LH, Han L, Xia R, Wang KM, Yang JS, et al: P53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression. Cell Death Dis. 5:e12432014. View Article : Google Scholar : PubMed/NCBI | |
|
Xu Y, Wang J, Qiu M and Xu L, Li M, Jiang F, Yin R and Xu L: Upregulation of the long noncoding RNA TUG1 promotes proliferation and migration of esophageal squamous cell carcinoma. Tumour Biol. 36:1643–1651. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Gong W, Zheng J, Liu X, Ma J, Liu Y and Xue Y: Knockdown of NEAT1 restrained the malignant progression of glioma stem cells by activating microRNA let-7e. Oncotarget. 7:62208–62223. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Yang X, Xiao Z, Du X, Huang L and Du G: Silencing of the long non-coding RNA NEAT1 suppresses glioma stem-like properties through modulation of the miR-107/CDK6 pathway. Oncol Rep. 37:555–562. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Mineo M, Ricklefs F, Rooj AK, Lyons SM, Ivanov P, Ansari KI, Nakano I, Chiocca EA, Godlewski J and Bronisz A: The long Non-coding RNA HIF1A-AS2 facilitates the maintenance of mesenchymal glioblastoma Stem-like cells in hypoxic niches. Cell Rep. 15:2500–2509. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Yu M, Xue Y, Zheng J, Liu X, Yu H, Liu L, Li Z and Liu Y: Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway. Mol Cancer. 16:1102017. View Article : Google Scholar : PubMed/NCBI | |
|
Coccia EM, Cicala C, Charlesworth A, Ciccarelli C, Rossi GB, Philipson L and Sorrentino V: Regulation and expression of a growth arrest-specific gene (gas5) during growth, differentiation, and development. Mol Cell Biol. 12:3514–3521. 1992. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao X, Liu Y, Zheng J, Liu X, Chen J, Liu L, Wang P and Xue Y: GAS5 suppresses malignancy of human glioma stem cells via a miR-196a-5p/FOXO1 feedback loop. Biochim Biophys Acta Mol Cell Res. 1864:1605–1617. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Jia P, Cai H, Liu X, Chen J, Ma J, Wang P, Liu Y, Zheng J and Xue Y: Long non-coding RNA H19 regulates glioma angiogenesis and the biological behavior of glioma-associated endothelial cells by inhibiting microRNA-29a. Cancer Lett. 381:359–369. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Ma Y, Wang P, Xue Y, Qu C, Zheng J, Liu X, Ma J and Liu Y: PVT1 affects growth of glioma microvascular endothelial cells by negatively regulating miR-186. Tumour Biol. 39:13933953382017. View Article : Google Scholar | |
|
Ma Y, Xue Y, Liu X, Qu C, Cai H, Wang P, Li Z, Li Z and Liu Y: SNHG15 affects the growth of glioma microvascular endothelial cells by negatively regulating miR-153. Oncol Rep. 38:3265–3277. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Wu T and Dai Y: Tumor microenvironment and therapeutic response. Cancer Lett. 387:61–68. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Q, Hu B, Hu X, Kim H, Squatrito M, Scarpace L, deCarvalho AC, Lyu S, Li P, Li Y, et al: Tumor evolution of Glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment. Cancer Cell. 32:42–56.e6. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Hanahan D and Coussens LM: Accessories to the crime: Functions of cells recruited to the tumor microenvironment. Cancer Cell. 21:309–322. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Shahar T, Rozovski U, Hess KR, Hossain A, Gumin J, Gao F, Fuller GN, Goodman L, Sulman EP and Lang FF: Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival. Neuro Oncol. 19:660–668. 2017.PubMed/NCBI | |
|
Yi D, Xiang W, Zhang Q, Cen Y, Su Q, Zhang F, Lu Y, Zhao H and Fu P: Human Glioblastoma-derived mesenchymal stem cell to pericytes transition and angiogenic capacity in glioblastoma microenvironment. Cellular physiology and Biochemistry. 46:279–290. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Q, Yi D, Xue B, Wen WW, Lu YP, Abdelmaksou A, Sun MX, Yuan DT, Zhao HY, Xiong NX, et al: CD90 determined two subpopulations of glioma-associated mesenchymal stem cells with different roles in tumour progression. Cell Death Dis. 9:11012018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Q, Xiang W, Yi D, Xue B, Wen W, Abdelmaksoud A, Xiong N, Jiang X, Zhao H and Fu P: Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas. Stem Cell Res Ther. 9:2282018. View Article : Google Scholar : PubMed/NCBI |
